135 related articles for article (PubMed ID: 9372905)
1. Fulminant hepatic failure associated with bicalutamide.
Schellhammer PF
Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
[No Abstract] [Full Text] [Related]
2. Bicalutamide-associated fulminant hepatic failure.
Chodak GW
Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
[No Abstract] [Full Text] [Related]
3. Fulminant hepatic failure associated with bicalutamide.
Dawson LA; Chow E; Morton G
Urology; 1997 Feb; 49(2):283-4. PubMed ID: 9037299
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
[TBL] [Abstract][Full Text] [Related]
5. Fatal fulminant hepatic failure due to cyproterone acetate.
Friedman G; Lamoureux E; Sherker AH
Dig Dis Sci; 1999 Jul; 44(7):1362-3. PubMed ID: 10489919
[TBL] [Abstract][Full Text] [Related]
6. Fulminant liver failure associated with flutamide therapy for hirsutism.
Andrade RJ; Lucena MI; Fernández MC; Suárez F; Montero JL; Fraga E; Hidalgo F
Lancet; 1999 Mar; 353(9157):983. PubMed ID: 10459914
[No Abstract] [Full Text] [Related]
7. Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Schröder FH
Prog Clin Biol Res; 1990; 359():93-103; discussion 105-7. PubMed ID: 2149460
[TBL] [Abstract][Full Text] [Related]
8. Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
Manolakopoulos S; Bethanis S; Armonis A; Economou M; Avgerinos A; Tzourmakliotis D
Dig Dis Sci; 2004 Mar; 49(3):462-5. PubMed ID: 15139499
[No Abstract] [Full Text] [Related]
9. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
10. Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect.
Bennett CL; Raisch DW; Sartor O
Ann Intern Med; 2002 Oct; 137(7):625. PubMed ID: 12353966
[No Abstract] [Full Text] [Related]
11. [Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study)].
Kitamura Y; Okuno H; Sakura Y; Manabe Y; Masuda N; Ito H; Mishina M; Taoka R; Terai A; Sugimoto M; Kakehi Y
Hinyokika Kiyo; 2014 Jan; 60(1):17-23. PubMed ID: 24594768
[TBL] [Abstract][Full Text] [Related]
12. Interstitial pneumonitis following bicalutamide treatment for prostate cancer.
McCaffrey JA; Scher HI
J Urol; 1998 Jul; 160(1):131. PubMed ID: 9628626
[No Abstract] [Full Text] [Related]
13. Bicalutamide-associated fulminant hepatotoxicity.
O'Bryant CL; Flaig TW; Utz KJ
Pharmacotherapy; 2008 Aug; 28(8):1071-5. PubMed ID: 18657023
[TBL] [Abstract][Full Text] [Related]
14. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
Furr BJ; Tucker H
Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
[TBL] [Abstract][Full Text] [Related]
15. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
Scher HI; Liebertz C; Kelly WK; Mazumdar M; Brett C; Schwartz L; Kolvenbag G; Shapiro L; Schwartz M
J Clin Oncol; 1997 Aug; 15(8):2928-38. PubMed ID: 9256137
[TBL] [Abstract][Full Text] [Related]
16. Photosensitive drug eruption induced by bicalutamide within the UVB action spectrum.
Sasada K; Sakabe J; Tamura A; Kasuya A; Shimauchi T; Ito T; Hirakawa S; Tokura Y
Eur J Dermatol; 2012; 22(3):402-3. PubMed ID: 22503957
[No Abstract] [Full Text] [Related]
17. The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Nuttall MC; Harris JP; Dawkins GP
BJU Int; 2007 Feb; 99(2):243-4. PubMed ID: 17313420
[No Abstract] [Full Text] [Related]
18. A case of male breast cancer in association with bicalutamide-induced gynaecomastia.
Chianakwalam CI; McCahy P; Griffiths NJ
Breast; 2005 Apr; 14(2):163-4. PubMed ID: 15767188
[No Abstract] [Full Text] [Related]
19. Drug-related hepatotoxicity and hepatic failure following combined androgen blockade.
Castro Beza I; Sánchez Ruiz J; Peracaula Espino FJ; Villanego Beltrán MI
Clin Transl Oncol; 2008 Sep; 10(9):591-2. PubMed ID: 18796378
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance as an adverse effect of leuprolide and bicalutamide treatment.
Paniagua MA; Hirsch IB
J Gerontol A Biol Sci Med Sci; 2005 Oct; 60(10):1283-4. PubMed ID: 16282560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
